help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on June 19, 2008, doi:10.1165/rcmb.2007-0424OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2007-0424OCv1
39/6/673    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suzuki, M.
Right arrow Articles by Nishimura, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suzuki, M.
Right arrow Articles by Nishimura, M.
American Journal of Respiratory Cell and Molecular Biology. Vol. 39, pp. 673-682, 2008
© 2008 American Thoracic Society
DOI: 10.1165/rcmb.2007-0424OC

Down-Regulated NF-E2–Related Factor 2 in Pulmonary Macrophages of Aged Smokers and Patients with Chronic Obstructive Pulmonary Disease

Masaru Suzuki1, Tomoko Betsuyaku1, Yoko Ito1, Katsura Nagai1, Yasuyuki Nasuhara1, Kichizo Kaga2, Satoshi Kondo2 and Masaharu Nishimura1

1 First Department of Medicine and 2 Department of Surgical Oncology, Hokkaido University School of Medicine, Sapporo, Japan

Correspondence and request for reprints should be addressed to Tomoko Betsuyaku, M.D., Ph.D., First Department of Medicine, Hokkaido University School of Medicine N-15, W-7, Kita-ku, Sapporo, 060-8638, Japan. E-mail: bytomoko{at}med.hokudai.ac.jp

Pulmonary macrophages are one of the sources of various antioxidant and detoxification enzymes for which NF-E2–related factor 2 (Nrf2) is a key transcriptional factor. Although Nrf2 deficiency reportedly induces severe emphysema in mice exposed to cigarette smoke (CS), no reports have studied Nrf2 regulation in chronic obstructive pulmonary disease (COPD). In this study, Nrf2 activation in response to CS was evaluated in human alveolar macrophages, and age-related differences in CS-induced Nrf2 regulation in mouse alveolar macrophages were determined. Furthermore, Nrf2 mRNA levels in human macrophages harvested by bronchoalveolar lavage or laser capture microdissection were measured. CS induced nuclear Nrf2 accumulation and up-regulation of Nrf2 target genes without substantial changes in Nrf2 mRNA levels in human alveolar macrophages. In humans, the Nrf2 mRNA level in lavaged macrophages of young subjects (n = 14) was independent of smoking status; however, the Nrf2 mRNA level was down-regulated in the lavaged macrophages of older current smokers (n = 14) compared with older nonsmokers (n = 9) (P < 0.001). Among older subjects, the macrophage Nrf2 mRNA level was inversely correlated with oxidized glutathione and carbonylated albumin levels in bronchoalveolar lavage fluid. In mice, aging suppressed the CS-induced up-regulation of Nrf2 target genes, as well as Nrf2, in alveolar macrophages. Furthermore, the Nrf2 mRNA level was decreased in laser capture microdissection–retrieved macrophages obtained from subjects with COPD (n = 10) compared with control subjects (n = 10) (P = 0.001). In conclusion, CS induces Nrf2 activation in macrophages, and Nrf2 expression is decreased in the macrophages of older current smokers and patients with COPD.

Key Words: cigarette smoking • bronchoalveolar lavage • laser capture microdissection


CLINICAL RELEVANCE

There have been no studies on the relationship between Nrf2 and chronic obstructive pulmonary disease (COPD). Acute cigarette smoke exposure leads to Nrf2 activation in human macrophages, and Nrf2 expression is decreased in pulmonary macrophages in current smokers and patients with COPD.

 



This article has been cited by other articles:


Home page
Proc Am Thorac SocHome page
W. MacNee and R. M. Tuder
New Paradigms in the Pathogenesis of Chronic Obstructive Pulmonary Disease I
Proceedings of the ATS, September 15, 2009; 6(6): 527 - 531.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Suzuki, T. Betsuyaku, Y. Ito, K. Nagai, N. Odajima, C. Moriyama, Y. Nasuhara, and M. Nishimura
Curcumin attenuates elastase- and cigarette smoke-induced pulmonary emphysema in mice
Am J Physiol Lung Cell Mol Physiol, April 1, 2009; 296(4): L614 - L623.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. E. Sussan, T. Rangasamy, D. J. Blake, D. Malhotra, H. El-Haddad, D. Bedja, M. S. Yates, P. Kombairaju, M. Yamamoto, K. T. Liby, et al.
From the Cover: Targeting Nrf2 with the triterpenoid CDDO- imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice
PNAS, January 6, 2009; 106(1): 250 - 255.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2008 American Thoracic Society.
  CCM abstracts